(Q47724186)

English

Modelling the cost-effectiveness of etanercept in adults with rheumatoid arthritis in the UK.

scientific article published on 30 July 2003

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/12890861

title

Modelling the cost-effectiveness of etanercept in adults with rheumatoid arthritis in the UK. (English)

1 reference

stated in

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/12890861

main subject

cost-effectiveness analysis

1 reference

1 reference

1

1 reference

stated in

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/12890861

Nick Bansback

series ordinal

2

1 reference

stated in

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/12890861

author name string

A Reynolds

series ordinal

3

1 reference

stated in

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/12890861

P Conway

series ordinal

4

1 reference

stated in

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/12890861

publication date

30 July 2003

1 reference

stated in

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/12890861

published in

Rheumatology

1 reference

stated in

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/12890861

volume

43

1 reference

stated in

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/12890861

issue

1

1 reference

stated in

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/12890861

page(s)

62-72

1 reference

stated in

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/12890861

Identifiers

DOI

10.1093/RHEUMATOLOGY/KEG451

1 reference

stated in

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/12890861

PubMed ID

12890861

1 reference

stated in

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/12890861

(Q47724186)

Modelling the cost-effectiveness of etanercept in adults with rheumatoid arthritis in the UK.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)